AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

RAT-HEMATO : Return to Work After Malignant Hemopathy

RecruitingNAAges 18 Years - 55 YearsAllUniversity Hospital, Angers
💬

In plain words

What the trial is, and whether it could suit you

Return to work (RTW) of patients after cancer treatment has been a topic of growing interest for the past two decades. Advances in cancer care have led to better patient survival, with some cancers considered as chronic or even cured diseases. The return of patients to their "pre-cancer life" can thus become an objective. Indeed, RTW after cancer is associated with improved quality of life for patients in several studies (improved financial status, improved social contacts, return of functional abilities and improved self-esteem). However, many difficulties can interfere with RTW. Many factors have been identified: disease, treatment, patient and occupational factors. The feeling of "return-to-work self-efficacy" is one of the main psychological determinants and its interest has been recently demonstrated in oncology. It corresponds to a cognitive mechanism based on expectations and/or b

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria : * Patient with hematological malignancy controlled after treatment * Induction/consolidation chemotherapy completed (excluding maintenance therapy) * Patient aged 18 to 55 * Patient having worked at least 6 months in the 2 years before diagnosis of hematological malignancy * Patient who has not yet returned to work since diagnosis of hematological malignancy * Signed informed consent form Exclusion Criteria: * Patient choosing not to return to work * Patient not affiliated to a social security system * Patient with legal guardian or legal trustee * Patient not understanding French * Patient with severe cognitive impairment at diagnosis, incompatible with the study
💊

What it tests

  • "Return-to-work after cancer" consultation
📍

Where

10 sites
Angers University hospital
Angers, France
Brest University Hospital, Morvan Site
Brest, France
Caen University hospital
Caen, France
Service Hématologie, Cholet Hospital
Cholet, France
Le Havre Hospital Group
Montivilliers, France
Pays de Morlaix Hospital
Morlaix, France
Rennes University Hospital, Pontchaillou site
Rennes, France
Centre Henri Becquerel
Rouen, France

…and 2 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy